Legal status by country
Is Sermorelin with GHRP-2 and GHRP-6 legal?
Written by Aaron CuhaReviewed Sep 2026
How Sermorelin with GHRP-2 and GHRP-6 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | Dispensed by compounding pharmacies on prescription. Compounded preparations are not FDA approved and are not reviewed for safety or efficacy. | Unlicensed; no MHRA marketing authorisation for any of the three. | None recorded | None recorded |
US FDA status: Not approved as a combination. Sermorelin held US approval and was withdrawn commercially; neither GHRP has ever been approved.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.